JPH0223967A - Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite - Google Patents

Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite

Info

Publication number
JPH0223967A
JPH0223967A JP63174812A JP17481288A JPH0223967A JP H0223967 A JPH0223967 A JP H0223967A JP 63174812 A JP63174812 A JP 63174812A JP 17481288 A JP17481288 A JP 17481288A JP H0223967 A JPH0223967 A JP H0223967A
Authority
JP
Japan
Prior art keywords
tricalcium phosphate
hydroxyapatite
mixed
acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63174812A
Other languages
Japanese (ja)
Inventor
Mamoru Nagase
守 永瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP63174812A priority Critical patent/JPH0223967A/en
Publication of JPH0223967A publication Critical patent/JPH0223967A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To easily impart a shape and to provide sufficient strength by mixing tricalcium phosphate, acid, polysaccharides and water and curing the resulting mixture. CONSTITUTION:An alpha-type tricalcium phosphate powder, glycolic acid being one of org. acids metabolized in a living body as an acid, dextran actually applied to a living body as a blood substitute preparation from a clinical aspect as one of water soluble polysaccharides, distilled water and granular or powdery hydroxyapatite are mixed as raw materials in a proper mixing ratio to be solidified and cured within several min. In actual mixing, glycolic acid and distilled water are mixed at first and dextran is added to the obtained mixture. The mixing ratio of these components is 6:25: 1 on a wt. basis. When the alpha-type tricalcium phosphate powder is added to the mixed acidic aqueous solution of polysaccharide 2, hydration/coagulation reaction is generated and the mixture becomes a solid cured material. When tricalcium phosphate 3 and hydroxyapatite 1 are mixed at this time to perform reaction, hydroxyapatite 1 is mixed in the coagulated cured material and the cured material becomes harder to be brought to a state hard to absorb.

Description

【発明の詳細な説明】 (イ)産業上の利用分野 本発明のリン酸三カルシウムと酸と多糖類と水と水酸ア
パタイトを混合する事により硬化生成した材料は、医療
上利用される。すなわち、この材料を主に人工骨として
生体に移植し、骨の代用物として利用する。あるいは人
工材料(たとえば人工関節など)と骨とを接着させる骨
セメントとして利用する。
DETAILED DESCRIPTION OF THE INVENTION (a) Field of Industrial Application The material hardened by mixing tricalcium phosphate, acid, polysaccharide, water and hydroxyapatite of the present invention is used medically. That is, this material is mainly transplanted into a living body as an artificial bone and used as a bone substitute. Alternatively, it can be used as bone cement to bond artificial materials (for example, artificial joints) and bone.

(ロ)従来の技術の欠点 従来の水酸アパタイトなどのセラミック材料による人工
骨は、焼成された物を生体に適合させていたが、これで
は形態付与が困難であり、また形成に時間がかかる。ま
た、粉末状あるいは顆粒状の水酸アパタイトなどを移植
した場合、生体内でこれらは散在してしまい希望する部
位に留まらないという欠点があった。また従来、人工関
節などを骨に接着する場合に用いられた骨セメントは−
1にMMAレジンが用いられており、これは手術中のシ
ョックや術後感染などの生体為害性の指摘が多く、これ
に変わる良い材料が焦い、一方、リン酸三カルシウムは
従来より人工骨材料として利用されているがこれは速や
かに生体に吸収されてしまう欠点があった。また、特に
a型のリン酸三カルシウム粉末は酸性水溶液との混合、
あるいは水と混合後加熱によりリン酸へカルシウムある
いは水酸アパタイトへ転化し凝結硬化することが知られ
ているがこのリン酸三カルシウムの水和凝結のみの生成
物は脆弱で人工骨として利用するには不適当であった。
(b) Disadvantages of conventional technology Conventional artificial bones made of ceramic materials such as hydroxyapatite were made by firing and making them compatible with living organisms, but this makes it difficult to give shape and takes time to form. . Furthermore, when powdered or granular hydroxyapatite is implanted, there is a drawback that it is scattered within the body and does not remain in the desired site. In addition, the bone cement traditionally used to bond artificial joints to bone is
1, MMA resin is used, and there are many indications that it is harmful to the body, such as shock during surgery and postoperative infection, and there is a need for a better material to replace it.On the other hand, tricalcium phosphate has been used for artificial bone. Although it is used as a material, it has the disadvantage that it is rapidly absorbed by living organisms. In particular, type A tricalcium phosphate powder can be mixed with an acidic aqueous solution,
Alternatively, it is known that by heating after mixing with water, phosphoric acid is converted into calcium or hydroxyapatite, which solidifies and hardens, but the product of only hydration and solidification of tricalcium phosphate is too fragile to be used as an artificial bone. was inappropriate.

(ハ)発明が解決しようとする問題点 本発明は上記の欠点を除くために発明されたものであり
、形態付与が容易で十分な強度を持ち。
(c) Problems to be Solved by the Invention The present invention was invented to eliminate the above-mentioned drawbacks, and it is easy to form and has sufficient strength.

組織親和性に優れた材料であり1人工骨材料あるいは骨
セメントとして利用可能な材料である。
It is a material with excellent tissue affinity and can be used as an artificial bone material or bone cement.

(ニ)問題点を解決するための手段と作用本発明は以前
私が出願した、特許WA rリン酸三カルシウムと酸と
多糖類と水を混合する事により硬化生成した人工骨j 
(特許出願番号6l−288495)の発明に水酸アパ
タイトを加えたものである。すなわち1本発明の人工骨
の原材料は主にα型のリン酸三カルシウム粉末と酸と水
溶性多糖類と水と顆粒状水酸アパタイトである。これら
の適した混合比の混合により、a型リン酸三カルシウム
と酸と水による水和凝結を中心とした反応により材料は
硬化する。この場合、多II類の存在が重要であり、多
糖類が存在することによりこの多糖類が骨格となり、凝
結物に十分な強度を与え1人工骨として使用に耐えつる
強度となる。また顆粒状あるいは粉末状の水酸アパタイ
トの添加は硬化した材料をより固くシ、吸収されにくく
するのに役立つ、この水酸アパタイトの混合比率は使用
目的に応じて加減し、また粒子の大きさも選択する。
(d) Means and action for solving the problems The present invention is based on a patent I previously applied for: Artificial bone produced by hardening by mixing tricalcium phosphate, acid, polysaccharide, and water.
(Patent Application No. 6l-288495) to which hydroxyapatite is added. That is, the raw materials for the artificial bone of the present invention are mainly α-type tricalcium phosphate powder, acid, water-soluble polysaccharide, water, and granular hydroxyapatite. By mixing these at an appropriate mixing ratio, the material is hardened by a reaction centered on hydration and coagulation between the a-type tricalcium phosphate, acid, and water. In this case, the presence of polysaccharide II is important; the presence of the polysaccharide makes this polysaccharide a skeleton and provides sufficient strength to the aggregate, making it strong enough to withstand use as an artificial bone. Also, the addition of granular or powdered hydroxyapatite helps to make the hardened material harder and less likely to be absorbed.The mixing ratio of this hydroxyapatite can be adjusted depending on the purpose of use, and the size of the particles can also be adjusted. select.

本発明の混合物が硬化するまでに数秒から数分を要する
が、その硬化の過程で任意の形態に形成することが可能
である0本発明による人工骨は形態付与が容易で、手術
中に形成する事が可能であり、これは画期的な材料であ
る。この手術中の人工骨の形成により従来の方法に比し
て手術の簡素化と時間雉縮が可能となる。また、硬化し
た本材料は組Il親和性に優れ人工骨として臨床応用す
るに十分なものと考えられる。
Although it takes several seconds to several minutes for the mixture of the present invention to harden, it is possible to form it into any desired shape during the hardening process.The artificial bone according to the present invention can be easily shaped and formed during surgery. This is an innovative material. This formation of artificial bone during surgery makes it possible to simplify the surgery and shorten the time compared to conventional methods. Furthermore, the cured material has excellent affinity for group Il and is considered to be sufficient for clinical application as an artificial bone.

また1本発明の材料を人工関節などの人工生体材料と骨
との結合を目的として骨セメントとして利用した場合、
術中骨内で本材料を硬化させる事により人工生体材料と
骨との十分な接着性が得られるが、従来の物に比して組
織親和性に優れた材料となる。
In addition, when the material of the present invention is used as a bone cement for the purpose of bonding an artificial biomaterial such as an artificial joint with bone,
By hardening this material within the bone during surgery, sufficient adhesion between the artificial biomaterial and the bone can be obtained, and the material has superior tissue affinity compared to conventional materials.

(ホ)実施例 実施例の一部を示すと、原材料は(lea型リシリン酸
三カルシウム粉末2)酸として生体内で代謝される有機
酸の一つであるグリコール酸、(3)水溶性多糖類とし
ては、血液代用製剤として臨床上実際生体に応用されて
いるデキストラン、陣)蒸留水、(5)顆粒状あるいは
粉末状の水酸アパタイト、を用い以上(1)〜(5)の
5者を適した混合比で混合することにより材料は数分で
凝結硬化する。実際混合する場合、まず、(2)グリコ
ール酸と(4)蒸留水を混合し、これに(3)デキスト
ランを加える。これらの混合比は重哩比で (2): 
 (31:  (4)=6:25:14が望ましい、こ
の混合された酸性の多糖類の水溶液に(+)a型リン酸
三カルシウム粉末を加えると水和凝結反応が起き混合物
は固い硬化物となる。この時(1)リン酸三カルシウム
と(5)水酸アパタイトを混合して反応させると水酸ア
パタイトが凝結硬化物内に混入され、硬化物がより固く
なり、また吸収されにくくなる。
(e) Example To show a part of the example, the raw materials are (lea type tricalcium ricylate powder 2) glycolic acid, which is one of the organic acids that is metabolized in the living body as an acid, (3) water-soluble polyester. As sugars, dextran, which is clinically applied to living organisms as a blood substitute, (5) distilled water, and (5) granular or powdered hydroxyapatite are used. By mixing them in the appropriate ratio, the material will solidify and harden in a few minutes. When actually mixing, first, (2) glycolic acid and (4) distilled water are mixed, and (3) dextran is added to this. The mixing ratio of these is the weight ratio (2):
(31: (4) = 6:25:14 is desirable. When (+) type A tricalcium phosphate powder is added to this mixed aqueous solution of acidic polysaccharides, a hydration-condensation reaction occurs and the mixture becomes a hard hardened product. At this time, when (1) tricalcium phosphate and (5) hydroxyapatite are mixed and reacted, hydroxyapatite will be mixed into the solidified and cured product, making the cured product harder and difficult to absorb. .

本発明で使用する酸は他のいかなる酸でも構わないが、
為害件の無いもの特に生体内で代謝される有機酸などが
望ましい、また、多糖類もいかなるものでも構わない、
また各混合比も場合に応じた混合比を選択すればよい。
The acid used in the present invention may be any other acid, but
Non-hazardous substances, especially organic acids that can be metabolized within the body, are preferable, and any polysaccharides are acceptable.
Further, each mixing ratio may be selected depending on the situation.

4、図の簡単な説明 第1図は本発明により生成した人工骨断面の予想模式拡
大図である。
4. Brief Description of the Figures Figure 1 is a schematic enlarged view of a cross section of an artificial bone produced according to the present invention.

図面番号lは水酸アパタイト顆粒、2は多糖類3はリン
酸三カルシウムが水和凝結してリン酸へカルシウムある
いは水酸アパタイトに転化したものである。
Drawing number 1 is hydroxyapatite granules, 2 is polysaccharide 3, and tricalcium phosphate is hydrated and condensed to convert into phosphoric acid or calcium or hydroxyapatite.

Claims (1)

【特許請求の範囲】[Claims] リン酸三カルシウムと酸と多糖類と水と水酸アパタイト
(ハイドロキシアパタイト)を混合することにより、混
合物は凝結硬化する。この方法により硬化生成した材料
の人工骨あるいはその他の生体材料としての利用
By mixing tricalcium phosphate, acid, polysaccharide, water, and hydroxyapatite, the mixture solidifies and hardens. Use of the material hardened by this method as artificial bone or other biomaterials
JP63174812A 1988-07-13 1988-07-13 Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite Pending JPH0223967A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63174812A JPH0223967A (en) 1988-07-13 1988-07-13 Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63174812A JPH0223967A (en) 1988-07-13 1988-07-13 Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite

Publications (1)

Publication Number Publication Date
JPH0223967A true JPH0223967A (en) 1990-01-26

Family

ID=15985099

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63174812A Pending JPH0223967A (en) 1988-07-13 1988-07-13 Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite

Country Status (1)

Country Link
JP (1) JPH0223967A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07102224B2 (en) * 1990-10-26 1995-11-08 サントル ナショナル ド ラ ルシェルシュ シアンティフィク(セ.エヌ.エル.エス.) Biodegradable implantable material and method of making same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07102224B2 (en) * 1990-10-26 1995-11-08 サントル ナショナル ド ラ ルシェルシュ シアンティフィク(セ.エヌ.エル.エス.) Biodegradable implantable material and method of making same

Similar Documents

Publication Publication Date Title
US4668295A (en) Surgical cements
JPH09509583A (en) Resorbable bioactive phosphate-containing cement
JPH03174311A (en) Storage-stable compound for on-site prepared calcium phosphate ore
GB2197329A (en) Hard tissue substitute composition
JPS6117409A (en) Preparation of amorphous calcium phosphate and bio-compatible composition composed mainly thereof
JPH0534987B2 (en)
WO2008039002A1 (en) High-strength calcium phosphate cements
JPS59182263A (en) Method for producing hardened calcium phosphate cement
JP2501213B2 (en) Bone glue
JPS63181770A (en) Artificial bone cured and formed by mixing calcium triphosphate, acid, protein and water
JP4669932B2 (en) Biomaterial composition and cured product thereof
JPH0223967A (en) Artificial bone cured and formed by mixing tricalcium phosphate, acid, polysaccharides, water and hydroxyapatite
JP3987220B2 (en) Fast-setting calcium phosphate cement
JPH0241171A (en) Artificial bone cured and formed by mixing tricalcium phosphate, acid, protein, water and hydroxyapatite
JP2563186B2 (en) Method for producing calcium phosphate-based cured product
JPS63143071A (en) Artificial bone cured and formed by mixing calcium triphosphate, acid, polysaccharide and water
JPH0699181B2 (en) Tetracalcium phosphate curable composition
JP2003320017A (en) Porous calcium phosphate and method for producing the same
JPH0526503B2 (en)
JPH0588623B2 (en)
JPS61236644A (en) Calcium phosphate hardenable composition
JPS61234868A (en) Curable composition
JP2548745B2 (en) Bone cement composition
JP2000169199A (en) Fast-setting calcium phosphate cement
JPH06339519A (en) Dental and medical granular bone filler allowed to fasten and manufacture thereof